Neu refix granted orphan disease designation (ODD) & rare pediatric disease designation (RPDD) by US FDA for treatment of ...
On August 6, 2024, the Food and Drug Administration (FDA) partnered with the Clinical Trials Transformation Initiative ...
A Gallup poll has found that consumers' confidence in food safety has dropped by 23 points between 2006 to 2024 ...
A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...
Vanda Pharmaceuticals said on Thursday the U.S. Food and Drug Administration declined to approve its drug to treat a type of ...
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
The U.S. Food and Drug Administration has declined to approve Vanda Pharmaceuticals' drug to treat stomach paralysis symptoms ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and ...